Advertisement
Forex News
Immunome And Morphimmune To Combine In All-stock Transaction
Biopharmaceutical company Immunome (IMNM) and private biotechnology company Morphimmune announced Thursday that they have entered into a definitive merger agreement to combine in an all-stock transaction.
RTTNews |
687 days ago
Paychex Guides FY24 Above Estimates - Update
While reporting financial results for the fourth quarter and fiscal 2023 on Thursday, payroll and HR services provider Paychex Inc. (PAYX) initiated adjusted earnings growth and revenue growth guidance for the full year 2024, above analysts' estimates.
RTTNews
|
687 days ago
Eurozone Economic Confidence Weakens In June
Eurozone economic sentiment weakened in June due to lower confidence in industry, construction and services, survey results from the European Commission showed on Thursday. At 95.3 in June, the economic sentiment index fell from 96.4 in May. The index hit the lowest since last November and was also below economists' forecast of 96.0.
RTTNews
|
687 days ago
U.S. GDP Growth In Q1 Unexpectedly Upwardly Revised
The U.S. economy grew by much more than previously estimated in the first quarter of 2023, according to revised data released by the Commerce Department on Thursday.
RTTNews
|
687 days ago
U.S. Weekly Jobless Claims Unexpectedly Decrease
The Labor Department released a report on Thursday showing an unexpected pullback by first-time claims for U.S. unemployment benefits in the week ended June 24th.
RTTNews
|
687 days ago
UK Mortgage Approvals Climb Despite Rising Interest Rates
British mortgage approvals increased more than expected in May despite the rising interest rates, but households started to reduce their reliance on credit and withdrew more money from their savings. The number of mortgages approved in May, an indicator of future borrowing, increased to 50,500 from 49,000 in April, the Bank of England said Thursday.
RTTNews
|
687 days ago
Endo International Says Health Canada Approves XCOPRI To Treat Epilepsy
Specialty pharmaceutical company Endo International plc (ENDPQ.PK) announced Thursday that its operating company Paladin Labs, Inc. (PLB.TO) has received Health Canada's approval of XCOPRI (cenobamate tablets) for adjunctive therapy in the management of partial-onset seizures in adults with epilepsy who are not satisfactorily controlled with conventional therapy.
RTTNews
|
687 days ago
more news
Bay Street Seen Opening On Mixed Note
Canadian shares likely to open on a mixed note on Thursday, as investors are likely to make cautious moves, tracking a mixed trend in commodities markets, and on concerns about further policy tightening by several central banks.
RTTNews
|
687 days ago
Carriage Services Initiates Process To Explore Potential Strategic Alternatives
Funeral and cemetery services firm Carriage Services, Inc. (CSV) announced Thursday that its Board of Directors has initiated a process to explore potential strategic alternatives, possibly including a sale, merger or other potential strategic or financial transaction, to maximize shareholder value.
RTTNews
|
687 days ago
Canadian Dollar Weakens On Interest Rate Concerns
The Canadian dollar dropped against its major counterparts in the European session on Thursday, as hawkish comments from major central bankers raised concerns about the interest rate outlook and the likelihood of a recession.
RTTNews
|
687 days ago
Eli Lilly To Acquire Sigilon Therapeutics
Eli Lilly and Co. (LLY) and Sigilon Therapeutics, Inc. (SGTX) announced Thursday a definitive agreement for Lilly to acquire Sigilon for up to $126.56 per share in cash or an aggregate of up to approximately $309.6 million.
RTTNews
|
687 days ago
European Shares Mixed Amid Rate, China Growth Worries
European stocks traded mixed on Thursday following hawkish comments from global central bank chiefs and amid continued uncertainty over slowing economic rebound in China.
RTTNews
|
687 days ago
FTSE 100 Slips Into Red On Interest Rate Worries
U.K. stocks slipped into the red on Thursday, a day after global central bank chiefs reaffirmed that further interest rate hikes will likely be needed to tame stubbornly high inflation.
RTTNews
|
687 days ago
Stay up to date!
Add News to your browser
Add To Chrome
